Related Party Note - Additional Information (Detail) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|
Jan. 11, 2016 |
May. 31, 2015 |
Mar. 20, 2015 |
Mar. 17, 2015 |
Feb. 17, 2015 |
Mar. 31, 2016 |
Mar. 31, 2015 |
Dec. 31, 2015 |
|
| Related Party Transaction [Line Items] | ||||||||
| Interest own in percent by principal stockholder or director | 15.40% | 14.80% | ||||||
| Costs and Expenses, Related Party | $ 63,000 | $ 40,000 | ||||||
| Lessee Leasing Arrangements, Operating Leases, Term of Contract | 5 years | |||||||
| Agreement Description Terms | (i) issue annually to the Company, on the anniversary date of the Founders Agreement, shares of common stock equal to to two and one half percent (2.5%) of the fully-diluted outstanding equity of Helocyte at the time of issuance; (ii) pay an equity fee in shares of Helocyte common stock, payable within five (5) business days of the closing of any equity or debt financing for Helocyte or any of its respective subsidiaries that occurs after the effective date of the Founders Agreement and ending on the date when Fortress no longer has majority voting control in Helocyte’s voting equity, equal to two and one half percent (2.5%) of the gross amount of any such equity or debt financing; and (iii) pay a cash fee equal to four and one half percent (4.5%) of our annual net sales, payable on an annual basis, within ninety (90) days of the end of each calendar year. In the event of a change in control (as it is defined in the Founders Agreement), the Company will pay a one-time change in control fee equal to five (5x) times the product of (i) monthly net sales for the twelve (12) months immediately preceding the change in control and (ii) four and one-half percent (4.5%). | (i) issue annually to the Company, on the anniversary date of the Founders Agreement, shares of Checkpoint common stock equal to two and one half percent (2.5%) of the fully-diluted outstanding equity of Checkpoint at the time of issuance; (ii) pay an equity fee in shares of Checkpoint common stock, payable within five (5) business days of the closing of any equity or debt financing for Checkpoint or any of its respective subsidiaries that occurs after the effective date of the Founders Agreement and ending on the date when the Company no longer has majority voting control in Checkpoint’s voting equity, equal to two and one half percent (2.5%) of the gross amount of any such equity or debt financing; and (iii) pay a cash fee equal to four and one half percent (4.5%) of its annual net sales, payable on an annual basis, within 90 days of the end of each calendar year. In the event of a change in control (as defined in the Founders Agreement), the Company will pay a one-time change in control fee equal to five times (5x) the product of (i) monthly net sales for the 12 months immediately preceding the change in control and (ii) four and one half percent (4.5%) | (i) issue annually to the Company, on the anniversary date of the Founders Agreement, shares of common stock equal to to two and one half percent (2.5%) of the fully-diluted outstanding equity of Avenue at the time of issuance; (ii) pay an equity fee in shares of Avenue common stock, payable within five (5) business days of the closing of any equity or debt financing for Avenue or any of its respective subsidiaries that occurs after the effective date of the Founders Agreement and ending on the date when Fortress no longer has majority voting control in Avenue’s voting equity, equal to two and one half percent (2.5%) of the gross amount of any such equity or debt financing; and (iii) pay a cash fee equal to four and one half percent (4.5%) of our annual net sales, payable on an annual basis, within ninety (90) days of the end of each calendar year. In the event of a change in control (as it is defined in the Founders Agreement), the Company will pay a one-time change in control fee equal to five (5x) times the product of (i) monthly net sales for the twelve (12) months immediately preceding the change in control and (ii) four and one-half percent (4.5%). | |||||
| Prepaid Rent | $ 199,000 | |||||||
| Lease Sharing Agreements, Contributions to Property Under Lease | 2,300,000 | |||||||
| Reimbursment Of Cost Recognised As Revenue | $ 300,000 | $ 300,000 | ||||||
| Chief Executive Officer [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Interest own in percent by principal stockholder or director | 12.90% | 12.20% | ||||||
| Chord Advisors, LLC [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Related Party Transaction, Expenses from Transactions with Related Party | $ 10,000 | |||||||
| Cb Pharma Acquisition Corp [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Working Capital | $ 500,000 | |||||||
| TG Therapeutics, Inc [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Accounts Receivable, Net, Total | 100,000 | |||||||
| Operating Leases, Rent Expense | 1,100,000 | |||||||
| Prepaid Rent | 79,800 | |||||||
| Due from Related Parties, Current | $ 1,000,000 | |||||||
| Percentage of Rentable Area | 40.00% | |||||||
| Lease Improvement Cost Assosciate With Lease | $ 5,100,000 | |||||||
| TG Therapeutics, Inc [Member] | Cb Pharma Acquisition Corp [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Payments for Fees | 300,000 | $ 200,000 | ||||||
| Checkpoint [Member] | Chord Advisors, LLC [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Related Party Transaction, Expenses from Transactions with Related Party | 7,500 | |||||||
| OPPM [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Operating Leases, Rent Expense | 500,000 | |||||||
| Prepaid Rent | 39,800 | |||||||
| Due from Related Parties, Current | $ 200,000 | |||||||
| Percentage of Rentable Area | 20.00% | |||||||
| Lease Improvement Cost Assosciate With Lease | $ 5,100,000 | |||||||
| Collaboration Agreement with TGTX [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Payments for Fees | 17,000,000,000 | $ 500,000 | 500,000 | |||||
| Collaboration Agreement with TGTX [Member] | TG Therapeutics, Inc [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Payments for Fees | $ 17,000 | $ 500,000 | ||||||
| Management Services Agreement [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Annual Consulting Fee | $ 500,000 | $ 500,000 | $ 500,000 | |||||
| Increase in Annual Consulting Fee | 1,000,000 | 1,000,000 | 1,000,000 | |||||
| Excess In Net Assets Value | $ 100,000,000 | 100,000,000 | 100,000,000 | |||||
| Management Services Agreement [Member] | Checkpoint [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Long-term Debt, Gross | $ 2,800,000 | |||||||
| Management Services Agreement [Member] | Founders Agreement [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Debt Issuance Cost | $ 3,000,000 | |||||||
| Avenue [Member] | Chord Advisors, LLC [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Related Party Transaction, Expenses from Transactions with Related Party | $ 5,000 | |||||||